SystImmune and Bristol Myers Squibb Announce a Global Strategic Collaboration Agreement for the Development and Commercialization of BL-B01D1 - Bristol-Myers Squibb news.bms.com Submitted by bmscom4434 on December 12, 2023 at 9:02 PM in business No comments 62